Kanoria Chemicals & Industries Limited
NSE:KANORICHEM.NS
138.16 (INR) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2012 Q4 | 2012 Q3 | 2012 Q2 | 2012 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 3,841.3 | 3,617.5 | 3,420.8 | 3,713.9 | 4,015 | 4,448.6 | 3,854.1 | 3,618.5 | 3,863.1 | 3,776.45 | 3,237.8 | 3,394.1 | 3,281.7 | 3,879.12 | 3,264.5 | 2,467.8 | 1,334.2 | 2,645.38 | 2,347.2 | 2,485.4 | 2,563.5 | 2,708.7 | 2,643.5 | 2,793 | 2,586.6 | 1,986.48 | 524.6 | 619.1 | 584.1 |
Cost of Revenue
| 3,462.2 | 3,010.8 | 3,001.1 | 2,592.8 | 2,845.6 | 3,178 | 2,735.5 | 2,560.9 | 2,688.1 | 2,901.31 | 2,319.2 | 2,348.5 | 2,262.4 | 2,911.13 | 2,050.5 | 1,658.1 | 885.8 | 1,966.8 | 1,587.3 | 1,790.1 | 1,742.1 | 2,180.84 | 1,789.6 | 1,916.3 | 1,709.9 | 746.58 | 512.5 | 566.2 | 565.9 |
Gross Profit
| 379.1 | 606.7 | 419.7 | 1,121.1 | 1,169.4 | 1,270.6 | 1,118.6 | 1,057.6 | 1,175 | 875.14 | 918.6 | 1,045.6 | 1,019.3 | 967.99 | 1,214 | 809.7 | 448.4 | 678.58 | 759.9 | 695.3 | 821.4 | 527.86 | 853.9 | 876.7 | 876.7 | 1,239.9 | 12.1 | 52.9 | 18.2 |
Gross Profit Ratio
| 0.099 | 0.168 | 0.123 | 0.302 | 0.291 | 0.286 | 0.29 | 0.292 | 0.304 | 0.232 | 0.284 | 0.308 | 0.311 | 0.25 | 0.372 | 0.328 | 0.336 | 0.257 | 0.324 | 0.28 | 0.32 | 0.195 | 0.323 | 0.314 | 0.339 | 0.624 | 0.023 | 0.085 | 0.031 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 6.45 | 0 | 0 | 0 | 12.74 | 0 | 0 | 0 | 25.57 | 0 | 0 | 0 | 36.19 | 0 | 0 | 0 | 38.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 510 | 475.1 | 550.4 | 451.1 | 603 | 457.6 | 409.1 | 499.8 | 510.9 | 561.75 | 470.3 | 495.6 | 348.2 | 378.3 | 434.7 | 388.9 | 322.1 | 453.32 | 389.6 | 387 | 407.9 | 455.72 | 370.7 | 379.5 | 360.2 | 0 | 0 | 0 | 0 |
Other Expenses
| 10.8 | -38.9 | 84.7 | -6.9 | 153.8 | -0.8 | 33 | -2.3 | 73.4 | -145 | 77 | -3.9 | 84.3 | -90.11 | 51.5 | 10.6 | 60 | -189.37 | 133 | 58 | 40.2 | -73.32 | 3.7 | 83.5 | 9.4 | 1,347.88 | 54.7 | 61.7 | 58.1 |
Operating Expenses
| 510 | 475.1 | 550.4 | 1,212.8 | 1,220.8 | 1,194 | 1,097.8 | 1,142.7 | 1,053 | 734.97 | 996.1 | 1,014.5 | 981.7 | 722.55 | 909.7 | 800.3 | 646.3 | 651.75 | 867.4 | 844.4 | 868.3 | 556.51 | 841.3 | 822.5 | 772.6 | 1,168.06 | 54.7 | 61.7 | 58.1 |
Operating Income
| -130.9 | 131.6 | -130.7 | -98.6 | -51.4 | 75.8 | 53.8 | -87.4 | 122 | 119.46 | -77.5 | 31.1 | 37.6 | 245.44 | 304.3 | 9.4 | -197.9 | 26.83 | -107.5 | -149.1 | -46.9 | -28.65 | 12.6 | 54.2 | 104.1 | 47.87 | -42.6 | -8.8 | -39.9 |
Operating Income Ratio
| -0.034 | 0.036 | -0.038 | -0.027 | -0.013 | 0.017 | 0.014 | -0.024 | 0.032 | 0.032 | -0.024 | 0.009 | 0.011 | 0.063 | 0.093 | 0.004 | -0.148 | 0.01 | -0.046 | -0.06 | -0.018 | -0.011 | 0.005 | 0.019 | 0.04 | 0.024 | -0.081 | -0.014 | -0.068 |
Total Other Income Expenses Net
| -99.2 | -111 | -5.5 | -112.6 | 18.6 | -105.9 | -100.1 | -80.2 | -0.1 | 49.88 | 7.4 | -66.4 | 29.8 | -86.2 | -42.7 | -82.1 | -36 | -119.65 | 38 | -30 | -40 | -74.7 | -131.5 | -14.9 | -70.9 | 34 | 17.8 | 36.8 | 70.4 |
Income Before Tax
| -230.1 | 20.6 | -136.2 | -211.2 | -32.8 | -30.1 | -46.3 | -167.6 | 121.9 | 169.34 | -70.1 | -35.3 | 67.4 | 159.24 | 261.6 | -72.7 | -233.9 | -92.82 | -69.5 | -179.1 | -86.9 | -103.35 | -118.9 | 39.3 | 33.2 | 81.87 | -24.8 | 28 | 30.5 |
Income Before Tax Ratio
| -0.06 | 0.006 | -0.04 | -0.057 | -0.008 | -0.007 | -0.012 | -0.046 | 0.032 | 0.045 | -0.022 | -0.01 | 0.021 | 0.041 | 0.08 | -0.029 | -0.175 | -0.035 | -0.03 | -0.072 | -0.034 | -0.038 | -0.045 | 0.014 | 0.013 | 0.041 | -0.047 | 0.045 | 0.052 |
Income Tax Expense
| 9.8 | 177.5 | 16.1 | -6 | 5.6 | -21.1 | -6.6 | -1.7 | 36.1 | -29.19 | 73.2 | 54.1 | 10.9 | -47.15 | 3.3 | 2 | -3.8 | -0.02 | -20.9 | -103.5 | 11.6 | -4.79 | -5.3 | 37.3 | 18 | 23.9 | 59.1 | 4.9 | 4.8 |
Net Income
| -196.2 | -92.6 | -81.3 | -183.7 | -26.4 | -15.2 | -12.7 | -142.5 | 82.7 | 183.46 | -108.2 | -56.4 | 49.4 | 199.33 | 233.1 | -73.5 | -213.7 | -79.8 | -37.8 | -60.9 | -79.4 | -75.55 | -116.9 | 19.1 | 24.1 | 54.93 | -24.8 | 23.1 | 25.7 |
Net Income Ratio
| -0.051 | -0.026 | -0.024 | -0.049 | -0.007 | -0.003 | -0.003 | -0.039 | 0.021 | 0.049 | -0.033 | -0.017 | 0.015 | 0.051 | 0.071 | -0.03 | -0.16 | -0.03 | -0.016 | -0.025 | -0.031 | -0.028 | -0.044 | 0.007 | 0.009 | 0.028 | -0.047 | 0.037 | 0.044 |
EPS
| -4.49 | -2.12 | -1.86 | -4.2 | -0.6 | -0.35 | -0.29 | -3.26 | 1.89 | 4.2 | -2.48 | -1.29 | 1.13 | 4.56 | 5.33 | -1.68 | -4.89 | -1.83 | -0.86 | -1.39 | -1.82 | -1.73 | -2.68 | 0.44 | 0.55 | 1.26 | -0.44 | 0.41 | 0.46 |
EPS Diluted
| -4.49 | -2.12 | -1.86 | -4.2 | -0.6 | -0.35 | -0.29 | -3.26 | 1.89 | 4.17 | -2.48 | -1.29 | 1.13 | 4.56 | 5.33 | -1.68 | -4.89 | -1.82 | -0.86 | -1.39 | -1.82 | -1.73 | -2.68 | 0.44 | 0.55 | 1.26 | -0.44 | 0.41 | 0.46 |
EBITDA
| 18 | 287.8 | 28.1 | 54.1 | 259.7 | 230.3 | 199.3 | 57.2 | 340.1 | 285.87 | 143.3 | 171.1 | 263.9 | 395.93 | 501.8 | 168.7 | 6.4 | 106.17 | 170.1 | 40.6 | 129.6 | 68.05 | 140.4 | 263.9 | 235.3 | 156.07 | 48.1 | 72.8 | 78.1 |
EBITDA Ratio
| 0.005 | 0.08 | 0.008 | 0.015 | 0.065 | 0.052 | 0.052 | 0.016 | 0.088 | 0.076 | 0.044 | 0.05 | 0.08 | 0.102 | 0.154 | 0.068 | 0.005 | 0.04 | 0.072 | 0.016 | 0.051 | 0.025 | 0.053 | 0.094 | 0.091 | 0.079 | 0.092 | 0.118 | 0.134 |